Oseltamivir overuse at a Chicago hospital during the 2009 influenza pandemic and the poor predictive value of influenza-like illness criteria

Scandinavian Journal of Infectious Diseases

Volumn 44, Issue 4, 2012, Pages 306-311

  Aziz, Mariam ^a   Vasoo, Shawn ^a   Aziz, Zaid ^a   Patel, Sejal ^a   Eltoukhy, Noha ^a   Singh, Kamaljit ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

empiric; influenza like illness; Oseltamivir; overuse; pandemic 2009 H1N1 influenza

Indexed keywords

OSELTAMIVIR;

ADOLESCENT; ADULT; ARTICLE; BODY TEMPERATURE; CHILD; CONTROLLED STUDY; COUGHING; FEMALE; FEVER; HUMAN; INFLUENZA A (H1N1); MAJOR CLINICAL STUDY; MALE; MYALGIA; PANDEMIC INFLUENZA; PATIENT CARE; PRESCHOOL CHILD; PRESCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHINORRHEA; RISK ASSESSMENT; SCHOOL CHILD; UNITED STATES;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CHICAGO; CHILD; FEMALE; HUMANS; INAPPROPRIATE PRESCRIBING; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; ODDS RATIO; OSELTAMIVIR; PANDEMICS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 84858972796     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2011.619997     Document Type: Article

References (31)

1. Anonymous. Tamiflu - wrong message? Drug Ther Bull 2009;47:97.
2. World Health Organization. Pandemic (H1N1) 2009 - weekly update 83. Geneva: WHO; 2010. Available at: http://www.who.int/csr/don/2010-01-15/en/index. html (accessed March 1, 2010).
3. Crum-Cianflone N, Blair P, Faix D, Arnold J, Echols S, Sherman SS, et al. Clinical and epidemiologic characteristics of an outbreak of novel H1N1 (swine origin) influenza A virus among United States military beneficiaries. Clin Infect Dis 2009;49:1801-10.
4. Cao B, Li X, Mao Y, Wang J, Lu HZ, Chen YS, et al. Clinical features, treatments and prognosis of the initial cases of pandemic influenza H1N1 2009 virus infection in China. N Engl J Med 2009;361:2507-17.
5. Reed C, Angulo F, Swerdlow, Lipsitch M, Meltzer MI, Jernigan D, et al. Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerg Infect Dis 2009;15:2004-7.
6. World Health Organization. Human infection with pandemic A (H1N1) 2009 influenza virus: clinical observations in hospitalized patients, Americas, July 2009 - update. Wkly Epidemiol Rec 2009;84:305-8. Available at: http://www.who.int/wer/2009/wer8430/en/index.html (accessed March 1, 2010).
7. US Centers for Disease Control and Prevention (CDC). Updated CDC estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States, April 2009-April 10, 2010. Available at: http://www.cdc.gov/ h1n1flu/estimates-2009-h1n1.htm (accessed November 4, 2010).
8. Triggle N. BBC News. Swine flu drug hand-out service raises concerns. London, UK: BBC News; July 4, 2010. Available at: http://news.bbc.co.uk/2/hi/ health/10491328.stm (accessed February 24, 2010).
9. Lautenbach E, Saint S, Henderson DK, Harris AD. Initial response of health care institutions to emergence of H1N1 influenza: experiences, obstacles and perceived future needs. Clin Infect Dis 2010;50:523-7.
10. US Centers for Disease Control and Prevention (CDC). Interim guidance for clinicians on identifying and caring for patients with swine-origin influenza A (H1N1) virus infection. Atlanta, GA: CDC; 2009. Available at: http://www.cdc.gov/h1n1flu/identifyingpatients.htm (accessed November 3, 2009).
11. Illinois Department of Public Health (IDPH). 2009- 2010 Flu activity report. Chicago, IL: IDPH; 2010. Available at: http://www.idph.state.il.us/flu/ fluupdate09-10.htm (accessed February 23, 2011).
12. Graitcer SB, Gubareva L, Kamimoto L, Doshi S, Vandermeer M, Louie J, et al. Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States. Emerg Infect Dis 2011;17:255-7.
13. US Centers for Disease Control and Prevention (CDC). 2007-08 U.S. influenza season summary. Atlanta, GA: CDC; 2008. Available at: http://www.cdc.gov/flu/weekly/weeklyarchives2007-2008/07-08summary.htm (accessed November 9, 2010).
14. US Centers for Disease Control and Prevention (CDC). CDC flu activity and surveillance reports 2008-2009 influenza season week 39 ending October 3, 2009. Atlanta, GA: CDC; 2009. Available at: http://www.cdc.gov/flu/weekly/ weeklyarchives2008-2009/weekly39.htm (accessed November 9, 2010).
15. Bloom JD, Gong LI, Baltimore D. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 2010;328:1272-5.
16. Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O. Oseltamivir- resistant influenza viruses A (H1N1), Norway, 2007-08. Emerg Infect Dis 2009;15:155-62.
17. Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClinton RC, Marshall SA, et al. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA. 2009;301:1034-41.
18. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009;361:1935-44.
19. Domí nguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, et al. Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009;302:1880-7.
20. World Health Organization (WHO). Antiviral use and the risk of resistance pandemic (H1N1) 2009 - briefing note 12. Geneva: WHO; 2009. Available at: www.who.int/csr/disease/swineflu/notes/h1n1-antiviral-use-20090925/en/ (accessed March 1, 2010).
21. Peltola V, Reunanen T, Silvennoinen H, Heikkinen T. Accuracy of clinical diagnosis of influenza in outpatient children. Clin Infect Dis 2005;41:1198-2000.
22. Gerrard J, Keijzers G, Zhang P, Vossen C, Macbeth D. Clinical diagnostic criteria for isolating patients admitted to hospital with suspected influenza. Lancet 2009;374:1673.
23. Ong A, Chen M, Lin L, Tan AS, Nwe NW, Barkham T, et al. Improving the clinical diagnosis of influenza - a comparative analysis of new influenza A (H1N1) cases. PLoS One 2009;4:e8453.
24. Vasoo S, Stevens J, Singh K. Rapid antigen tests for diagnosis of pandemic (swine) influenza A/H1N1. Clin Infect Dis 2009;49:1090-3.
25. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. JAMA 2009;302:1896.
26. Louie JK, Acosta M, Jamieson DJ, Honein MA. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med 2010;362:27-35.
27. Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM. Antiviral agents for the treatment and chemoprophylaxis of influenza - recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention (CDC). MMWR Recomm Rep 2011:60:1-24.
28. Singh K, Vasoo S, Stevens J, Schreckenberger P, Trenholme G. Pitfalls in diagnosis of pandemic (novel) A/H1N1 2009 influenza. J Clin Microbiol 2010;48:1501-3.
29. Dryden MS, Cooke J, Davey P. Antibiotic stewardship - more education and regulation not more availability. J Antimicrob Chemother 2009;64:885-8.
30. Singh N, Rogers P, Atwood C, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit - a proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000;162:505-11. (Pubitemid 30647191)
31. Preslaski CR, Doody M, Price CS, Jenkins TC. Use of oseltamivir at an academic hospital: antimicrobial stewardship lessons from the H1N1 influenza pandemic. Abstract 109. Fifth Decennial International Conference on Healthcare-associated Infections, Atlanta, Georgia, USA, March 18-22, 2010. Available at: http://shea.confex.com/shea/2010/webprogram/Paper2100.html (accessed February 25, 2010).